Chardan Capital Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: Chardan Capital
Rating: 2.7
Author: MarketBeat

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Chardan Capital. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Chardan Capital.

Company	Date	Action	Brokerage	Analyst	Rating	Price Target	Impact on Price
EYPT EyePoint Pharmaceuticals	5/18/2023	Target Raised by	Chardan Capital			$21.00 -> $22.00	Low
FBRX Forte Biosciences	5/15/2023	Reiterated by	Chardan Capital	Analyst K. Nakae	Neutral		Low
KITT Nauticus Robotics	5/12/2023	Downgraded by	Chardan Capital		Buy -> Neutral	$2.50	Low
TNYA Tenaya Therapeutics	5/11/2023	Target Lowered by	Chardan Capital			$24.00 -> $23.00	Low
VLN Valens Semiconductor	5/11/2023	Target Lowered by	Chardan Capital		Buy	$13.00 -> $12.00	Low
QURE uniQure	5/10/2023	Target Lowered by	Chardan Capital			$60.00 -> $56.00	Low

OCGN Ocugen	5/7/2023	Target Raised by	Chardan Capital	Analyst D. Gataulin		$3.50 -> $4.00	Low
RCKT Rocket Pharmaceuticals	5/5/2023	Target Lowered by	Chardan Capital			$63.00 -> $61.00	Low
RGNX REGENXBIO	5/4/2023	Target Lowered by	Chardan Capital			$61.00 -> $55.00	Low
MCRB Seres Therapeutics	4/28/2023	Target Lowered by	Chardan Capital			$12.00 -> $10.00	Low
WBX Wallbox	4/18/2023	Reiterated by	Chardan Capital		Buy	$12.00	Low
IMRX Immuneering	4/18/2023	Target Raised by	Chardan Capital		Buy	$18.00 -> $22.00	Low
OCGN Ocugen	4/14/2023	Reiterated by	Chardan Capital	Analyst D. Gataulin	Buy	$3.50	Low
CLSK CleanSpark	4/17/2023	Reiterated by	Chardan Capital		Buy	$5.00	Low
NVVE Nuvve	4/3/2023	Reiterated by	Chardan Capital		Buy	$2.50	Low
MARA Marathon Digital	4/3/2023	Reiterated by	Chardan Capital		Buy	$15.00	Low
BTTX Better Therapeutics	3/31/2023	Target Lowered by	Chardan Capital		Buy	$14.00 -> $9.00	Low
COYA Coya Therapeutics	3/30/2023	Reiterated by	Chardan Capital	Analyst K. Nakae	Buy	$9.00	Low
RNA Avidity Biosciences	3/31/2023	Reiterated by	Chardan Capital		Buy	$27.00	N/A
FEMY Femasys	3/30/2023	Target Lowered by	Chardan Capital		Buy	$12.00 -> $10.00	Low
TSHA Taysha Gene Therapies	3/29/2023	Target Lowered by	Chardan Capital		Buy	$6.00 -> $5.00	Low
SYBX Synlogic	3/29/2023	Target Lowered by	Chardan Capital		Buy	$7.00 -> $5.50	Low
MARA Marathon Digital	3/28/2023	Target Lowered by	Chardan Capital		Buy	$17.00 -> $15.00	Low
BMTX BM Technologies	3/29/2023	Reiterated by	Chardan Capital		Buy	$13.00	Low
AMTI Applied Molecular Transport	3/28/2023	Downgraded by	Chardan Capital		Buy -> Neutral		Low
NVVE Nuvve	3/27/2023	Target Lowered by	Chardan Capital		Buy	$11.00 -> $2.50	Low
GANX Gain Therapeutics	3/27/2023	Target Raised by	Chardan Capital			$4.00 -> $5.75	Low
OUST Ouster	3/24/2023	Downgraded by	Chardan Capital		Buy -> Neutral	$10.00	Low
SNTI Senti Biosciences	3/23/2023	Target Lowered by	Chardan Capital		Buy	$8.00 -> $7.00	Low
IMTX Immatics	3/23/2023	Target Lowered by	Chardan Capital		Buy	$28.00 -> $25.00	Low
COYA Coya Therapeutics	3/22/2023	Reiterated by	Chardan Capital	Analyst K. Nakae	Buy	$9.00	Low
ANIX Anixa Biosciences	3/22/2023	Reiterated by	Chardan Capital	Analyst M. Barcus	Buy	$8.00 -> $9.00	Low
CABA Cabaletta Bio	3/22/2023	Reiterated by	Chardan Capital		Buy	$12.00	Low
IPSC Century Therapeutics	3/22/2023	Reiterated by	Chardan Capital	Analyst G. Livshits	Buy	$19.00	Low
IMNM Immunome	3/16/2023	Target Lowered by	Chardan Capital		Buy	$9.00 -> $8.00	Low
CRGO Freightos	3/16/2023	Target Lowered by	Chardan Capital		Buy	$13.00 -> $11.00	Low
MGTX MeiraGTx	3/16/2023	Target Lowered by	Chardan Capital		Buy	$47.00 -> $41.00	Low
SLN Silence Therapeutics	3/16/2023	Target Lowered by	Chardan Capital		Buy	$29.00 -> $26.00	Low
PRVB Provention Bio	3/13/2023	Target Lowered by	Chardan Capital		Buy	$30.00 -> $25.00	Low
NRGV Energy Vault	3/9/2023	Target Lowered by	Chardan Capital		Buy	$13.00 -> $7.00	Low

TNYA Tenaya Therapeutics	3/9/2023	Target Lowered by	Chardan Capital		Buy	$28.00 -> $24.00	Low
MCRB Seres Therapeutics	3/8/2023	Reiterated by	Chardan Capital		Buy	$12.00	Low
ACHL Achilles Therapeutics	3/8/2023	Target Lowered by	Chardan Capital			$17.00 -> $12.00	Low
IMRX Immuneering	3/7/2023	Reiterated by	Chardan Capital		Buy	$18.00	N/A
AMTI Applied Molecular Transport	3/6/2023	Reiterated by	Chardan Capital		Buy		Low
EYPT EyePoint Pharmaceuticals	3/3/2023	Reiterated by	Chardan Capital		Buy	$21.00	Low
GWH ESS Tech	3/3/2023	Target Lowered by	Chardan Capital		Neutral	$4.50 -> $1.80	Low
VLN Valens Semiconductor	3/3/2023	Reiterated by	Chardan Capital		Buy	$13.00	Low
ABUS Arbutus Biopharma	3/3/2023	Reiterated by	Chardan Capital		Buy	$6.00	Low
DYN Dyne Therapeutics	3/3/2023	Target Raised by	Chardan Capital		Buy	$17.00 -> $20.00	Low
RGNX REGENXBIO	3/2/2023	Reiterated by	Chardan Capital		Buy	$61.00	Low
IOVA Iovance Biotherapeutics	3/1/2023	Reiterated by	Chardan Capital	Analyst Geulah Livshits	Buy	$29.00	Low
MESO Mesoblast	3/1/2023	Reiterated by	Chardan Capital		Sell	$2.50	Low
RNA Avidity Biosciences	3/1/2023	Reiterated by	Chardan Capital		Buy	$27.00	Low
OCGN Ocugen	3/1/2023	Upgraded by	Chardan Capital	Analyst D. Gataulin	Neutral -> Buy	$3.50	Low
RCKT Rocket Pharmaceuticals	3/1/2023	Target Lowered by	Chardan Capital		Buy	$65.00 -> $63.00	Low
KRYS Krystal Biotech	2/28/2023	Reiterated by	Chardan Capital		Buy	$133.00	Low
QURE uniQure	2/28/2023	Reiterated by	Chardan Capital		Buy	$60.00	Low
LICY Li-Cycle	2/28/2023	Reiterated by	Chardan Capital		Buy	$10.00	Low
CRGO Freightos	2/28/2023	Reiterated by	Chardan Capital		Buy		Low
NTLA Intellia Therapeutics	2/24/2023	Target Lowered by	Chardan Capital	Analyst Geulah Livshits	Buy	$129.00 -> $111.00	Low
WBX Wallbox	2/24/2023	Target Lowered by	Chardan Capital		Buy	$13.00 -> $12.00	Low
ALNY Alnylam Pharmaceuticals	2/24/2023	Reiterated by	Chardan Capital		Buy	$250.00	Low
EDIT Editas Medicine	2/23/2023	Target Lowered by	Chardan Capital		Buy	$35.00 -> $22.00	Low
PET Wag! Group	2/22/2023	Target Raised by	Chardan Capital		Buy	$5.00 -> $8.00	Low
CRSP CRISPR Therapeutics	2/22/2023	Target Lowered by	Chardan Capital		Buy	$153.00 -> $123.00	Low
FREQ Frequency Therapeutics	2/15/2023	Downgraded by	Chardan Capital	Analyst D. Gataulin	Buy -> Neutral		Low
PLBY PLBY Group	2/13/2023	Reiterated by	Chardan Capital		Buy	$5.00	Low
DFLI Dragonfly Energy	2/10/2023	Target Lowered by	Chardan Capital		Buy	$15.00 -> $10.00	Low
ARWR Arrowhead Pharmaceuticals	2/10/2023	Reiterated by	Chardan Capital		Buy	$60.00	Low
PPBT Purple Biotech	2/9/2023	Reiterated by	Chardan Capital	Analyst M. Barcus	Buy	$11.00	Low
BMTX BM Technologies	2/7/2023	Target Lowered by	Chardan Capital		Buy	$21.00 -> $13.00	Low
OBIO Orchestra BioMed	2/7/2023	Initiated by	Chardan Capital	Analyst K. Nakae	Buy	$20.00	Low
IMVT Immunovant	2/5/2023	Target Raised by	Chardan Capital		Buy	$19.00 -> $21.00	Low
TSHA Taysha Gene Therapies	2/1/2023	Target Lowered by	Chardan Capital		Buy	$16.00 -> $6.00	Low
LICY Li-Cycle	1/31/2023	Target Lowered by	Chardan Capital		Buy	$13.00 -> $10.00	Low
SNTI Senti Biosciences	1/27/2023	Target Lowered by	Chardan Capital		Buy	$12.00 -> $8.00	Low
COYA Coya Therapeutics	1/26/2023	Initiated by	Chardan Capital	Analyst K. Nakae	Buy	$9.00	N/A
MRNA Moderna	1/18/2023	Target Raised by	Chardan Capital	Analyst Y. Livshits	Neutral	$191.00 -> $208.00	Low
ARWR Arrowhead Pharmaceuticals	1/10/2023	Target Lowered by	Chardan Capital			$82.00 -> $60.00	Low
GIAC Gesher I Acquisition	12/27/2022	Initiated by	Chardan Capital		Buy	$13.00	Low
IPSC Century Therapeutics	12/27/2022	Initiated by	Chardan Capital	Analyst G. Livshits	Buy	$19.00	Low
ANIX Anixa Biosciences	12/23/2022	Initiated by	Chardan Capital		Buy	$8.00	Low
XLO Xilio Therapeutics	12/21/2022	Initiated by	Chardan Capital	Analyst M. Barcus	Buy	$7.00	Low
CLSK CleanSpark	12/15/2022	Target Lowered by	Chardan Capital		Buy	$6.00 -> $5.00	Low
PASG Passage Bio	12/15/2022	Target Lowered by	Chardan Capital		Buy	$18.00 -> $11.00	Low
MRNA Moderna	12/14/2022	Downgraded by	Chardan Capital	Analyst Y. Livshits	Buy -> Neutral	$186.00 -> $191.00	Low
GANX Gain Therapeutics	12/9/2022	Initiated by	Chardan Capital		Buy	$4.00	Low
FREQ Frequency Therapeutics	12/8/2022	Initiated by	Chardan Capital	Analyst D. Gataulin	Buy	$7.00	Low
ACHL Achilles Therapeutics	12/6/2022	Target Lowered by	Chardan Capital		Buy	$20.00 -> $17.00	Low

AMTI Applied Molecular Transport	12/2/2022	Initiated by	Chardan Capital		Buy		Low
SQZ SQZ Biotechnologies	12/1/2022	Target Lowered by	Chardan Capital		Buy	$16.00 -> $4.00	Low
PRVB Provention Bio	11/18/2022	Target Raised by	Chardan Capital		Buy	$24.00 -> $30.00	Low
IOVA Iovance Biotherapeutics	11/18/2022	Target Lowered by	Chardan Capital		Buy	$30.00 -> $29.00	Low
DFLI Dragonfly Energy	11/18/2022	Initiated by	Chardan Capital		Buy	$15.00	Low
EDIT Editas Medicine	11/17/2022	Target Lowered by	Chardan Capital		Buy	$43.00 -> $35.00	Low
SLN Silence Therapeutics	11/17/2022	Target Lowered by	Chardan Capital		Buy	$33.00 -> $29.00	Low
FIXX Homology Medicines	11/17/2022	Target Lowered by	Chardan Capital	Analyst M. Barcus	Buy -> Buy	$10.00 -> $8.00	Low
VINC Vincerx Pharma	11/16/2022	Target Lowered by	Chardan Capital		Buy	$4.00 -> $3.00	Low
EVLO Evelo Biosciences	11/16/2022	Downgraded by	Chardan Capital	Analyst K. Nakae	Buy -> Neutral	$2.50	Low
BTTX Better Therapeutics	11/15/2022	Target Lowered by	Chardan Capital		Buy	$17.00 -> $14.00	Low
PDSB PDS Biotechnology	11/14/2022	Target Raised by	Chardan Capital		Buy	$15.00 -> $16.00	Low
NTLA Intellia Therapeutics	11/14/2022	Target Raised by	Chardan Capital	Analyst Geulah Livshits	Buy	$121.00 -> $129.00	Low
CABA Cabaletta Bio	11/11/2022	Target Lowered by	Chardan Capital		Buy	$13.00 -> $12.00	Low
ADVM Adverum Biotechnologies	11/11/2022	Target Lowered by	Chardan Capital		Neutral	$2.50 -> $2.00	Low
TNYA Tenaya Therapeutics	11/11/2022	Target Lowered by	Chardan Capital		Buy	$30.00 -> $28.00	Low
SYBX Synlogic	11/11/2022	Target Lowered by	Chardan Capital	Analyst Keay Nakae	Buy	$9.00 -> $7.00	Low
FEMY Femasys	11/11/2022	Target Lowered by	Chardan Capital		Buy	$15.00 -> $12.00	Low
SQZ SQZ Biotechnologies	11/10/2022	Target Lowered by	Chardan Capital	Analyst G. Livshits	Buy	$17.00 -> $16.00	Low
TSHA Taysha Gene Therapies	11/9/2022	Target Lowered by	Chardan Capital		Buy	$32.00 -> $16.00	Low
EBS Emergent BioSolutions	11/9/2022	Target Lowered by	Chardan Capital		Buy	$65.00 -> $55.00	Low
VTRS Viatris	11/7/2022	Downgraded by	Chardan Capital		Buy -> Neutral		N/A
KRYS Krystal Biotech	11/7/2022	Target Raised by	Chardan Capital		Buy	$130.00 -> $133.00	Low
IMVT Immunovant	11/7/2022	Target Raised by	Chardan Capital		Buy	$12.00 -> $19.00	Low
MRNA Moderna	11/7/2022	Target Lowered by	Chardan Capital		Buy	$188.00 -> $186.00	Low
GWH ESS Tech	11/4/2022	Target Lowered by	Chardan Capital		Neutral	$5.00 -> $4.50	Low
RGNX REGENXBIO	11/4/2022	Target Lowered by	Chardan Capital		Buy	$70.00 -> $61.00	Low
PRVB Provention Bio	11/4/2022	Target Raised by	Chardan Capital		Buy	$21.00 -> $24.00	N/A
NTLA Intellia Therapeutics	11/3/2022	Target Lowered by	Chardan Capital	Analyst Geulah Livshits	Buy	$146.00 -> $121.00	Low
EDIT Editas Medicine	11/2/2022	Target Lowered by	Chardan Capital		Buy	$60.00 -> $43.00	Low
AXLA Axcella Health	11/2/2022	Target Lowered by	Chardan Capital	Analyst Keay Nakae	Buy	$7.00 -> $5.00	Low
CORZ Core Scientific	10/28/2022	Downgraded by	Chardan Capital		Buy -> Neutral		Low
CLSK CleanSpark	10/28/2022	Target Lowered by	Chardan Capital		Buy	$9.00 -> $6.00	Low
PLBY PLBY Group	10/21/2022	Target Lowered by	Chardan Capital		Buy	$9.00 -> $5.00	Low
KITT Nauticus Robotics	10/10/2022	Initiated by	Chardan Capital		Buy	$11.00	Low
RCKT Rocket Pharmaceuticals	9/30/2022	Target Raised by	Chardan Capital		Buy	$62.00 -> $65.00	Low
PET Wag! Group	9/30/2022	Initiated by	Chardan Capital		Buy	$5.00	Low
IMVT Immunovant	9/29/2022	Target Lowered by	Chardan Capital	Analyst M. Barcus	Buy	$14.00 -> $12.00	Low
RNA Avidity Biosciences	9/27/2022	Target Lowered by	Chardan Capital	Analyst K. Nakae	Buy	$29.00 -> $27.00	Low
OMGA Omega Therapeutics	9/23/2022	Initiated by	Chardan Capital		Buy	$12.00	Low
SNTI Senti Biosciences	9/22/2022	Initiated by	Chardan Capital		Buy	$12.00	Low
NTLA Intellia Therapeutics	9/16/2022	Reiterated by	Chardan Capital	Analyst Geulah Livshits	Buy	$146.00	Low
LICY Li-Cycle	9/15/2022	Target Lowered by	Chardan Capital		Buy	$18.00 -> $13.00	Low
OTLK Outlook Therapeutics	9/13/2022	Initiated by	Chardan Capital		Buy		Low
PPBT Purple Biotech	9/8/2022	Initiated by	Chardan Capital	Analyst M. Barcus	Buy	$11.00	Low
FBRX Forte Biosciences	8/17/2022	Downgraded by	Chardan Capital	Analyst K. Nakae	Buy -> Neutral		Low
FIXX Homology Medicines	8/16/2022	Target Lowered by	Chardan Capital	Analyst M. Barcus	Buy -> Buy	$14.00 -> $10.00	Low
EVLO Evelo Biosciences	8/15/2022	Target Lowered by	Chardan Capital		Buy	$12.00 -> $5.00	Low
GWH ESS Tech	8/15/2022	Target Raised by	Chardan Capital		Neutral	$3.50 -> $5.00	Low
CLSK CleanSpark	8/15/2022	Target Raised by	Chardan Capital		Buy	$7.00 -> $9.00	Low

ADVM Adverum Biotechnologies	8/12/2022	Target Lowered by	Chardan Capital	Analyst D. Gataulin	Neutral	$3.00 -> $2.50	Low
MGTX MeiraGTx	8/12/2022	Target Raised by	Chardan Capital	Analyst Geulah Livshits	Buy	$46.00 -> $47.00	Low
TSHA Taysha Gene Therapies	8/12/2022	Target Lowered by	Chardan Capital		Buy	$34.00 -> $32.00	Low
SLDB Solid Biosciences	8/12/2022	Target Lowered by	Chardan Capital		Buy	$105.00 -> $90.00	Low
CABA Cabaletta Bio	8/12/2022	Target Lowered by	Chardan Capital		Buy	$17.00 -> $13.00	Low
PRQR ProQR Therapeutics	8/12/2022	Downgraded by	Chardan Capital	Analyst K. Nakae	Buy -> Neutral		Low
SABS SAB Biotherapeutics	8/11/2022	Target Lowered by	Chardan Capital		Buy	$7.00 -> $3.00	Low
TNYA Tenaya Therapeutics	8/11/2022	Target Lowered by	Chardan Capital		Buy	$31.00 -> $30.00	Low
IMTX Immatics	8/10/2022	Target Lowered by	Chardan Capital		Buy	$30.00 -> $28.00	Low
KOD Kodiak Sciences	8/10/2022	Target Lowered by	Chardan Capital	Analyst D. Gataulin	Buy	$19.00 -> $18.00	Low
PLBY PLBY Group	8/10/2022	Target Lowered by	Chardan Capital		Buy	$13.00 -> $9.00	Low
QURE uniQure	8/9/2022	Target Lowered by	Chardan Capital	Analyst M. Barcus	Buy	$65.00 -> $60.00	Low
CRSP CRISPR Therapeutics	8/9/2022	Target Lowered by	Chardan Capital		Buy	$164.00 -> $154.00	Low
KRYS Krystal Biotech	8/9/2022	Target Lowered by	Chardan Capital		Buy	$137.00 -> $130.00	Low
NVVE Nuvve	8/8/2022	Target Lowered by	Chardan Capital		Buy	$24.00 -> $11.00	Low
ARWR Arrowhead Pharmaceuticals	8/5/2022	Target Raised by	Chardan Capital			$80.00 -> $82.00	Low
IOVA Iovance Biotherapeutics	8/5/2022	Target Lowered by	Chardan Capital			$31.00 -> $30.00	Low
PASG Passage Bio	8/5/2022	Target Lowered by	Chardan Capital			$34.00 -> $18.00	Low
PRVB Provention Bio	8/5/2022	Target Lowered by	Chardan Capital		Buy	$22.50 -> $21.00	Low
NTLA Intellia Therapeutics	8/5/2022	Target Lowered by	Chardan Capital		Buy	$172.00 -> $146.00	Low
MCRB Seres Therapeutics	8/4/2022	Target Lowered by	Chardan Capital			$16.00 -> $12.00	Low
ALNY Alnylam Pharmaceuticals	8/4/2022	Target Raised by	Chardan Capital	Analyst Keay Nakae	Buy	$200.00 -> $250.00	Low
PLBY PLBY Group	8/3/2022	Target Lowered by	Chardan Capital		Buy	$21.00 -> $13.00	Low
VBLT Vascular Biogenics	7/20/2022	Downgraded by	Chardan Capital	Analyst M. Barcus	Buy -> Neutral		Low
DYN Dyne Therapeutics	7/20/2022	Initiated by	Chardan Capital		Buy	$17.00	Low
RNA Avidity Biosciences	7/20/2022	Initiated by	Chardan Capital	Analyst K. Nakae	Buy	$29.00	Low
IMRX Immuneering	7/8/2022	Initiated by	Chardan Capital		Buy	$18.00	N/A
EYPT EyePoint Pharmaceuticals	7/7/2022	Initiated by	Chardan Capital	Analyst D. Gataulin	Buy	$21.00	N/A
SLDP Solid Power	6/29/2022	Initiated by	Chardan Capital		Buy	$8.00	Low
NRGV Energy Vault	6/29/2022	Initiated by	Chardan Capital		Buy	$13.00	Low
GWH ESS Tech	6/29/2022	Initiated by	Chardan Capital		Neutral	$3.50	Low
CRSP CRISPR Therapeutics	6/22/2022	Target Lowered by	Chardan Capital		Buy	$168.00 -> $164.00	Low
SYBX Synlogic	6/10/2022	Reiterated by	Chardan Capital	Analyst Keay Nakae	Buy	$9.00	High
VINC Vincerx Pharma	6/7/2022	Target Lowered by	Chardan Capital	Analyst M. Barcus	Buy	$11.00 -> $4.00	High
MESO Mesoblast	6/3/2022	Target Lowered by	Chardan Capital		Sell	$6.50 -> $2.50	Low
MARA Marathon Digital	6/3/2022	Initiated by	Chardan Capital		Buy	$19.00	Low
CORZ Core Scientific	6/3/2022	Initiated by	Chardan Capital		Buy	$8.00	High
CLSK CleanSpark	6/3/2022	Initiated by	Chardan Capital		Buy	$12.00	Low
IOVA Iovance Biotherapeutics	5/27/2022	Target Lowered by	Chardan Capital		Buy	$44.00 -> $31.00	High
SQZ SQZ Biotechnologies	5/25/2022	Initiated by	Chardan Capital	Analyst G. Livshits	Buy	$17.00	High
RCKT Rocket Pharmaceuticals	5/19/2022	Target Raised by	Chardan Capital		Buy	$60.00 -> $62.00	High
TSHA Taysha Gene Therapies	5/17/2022	Target Lowered by	Chardan Capital			$37.00 -> $34.00	Medium
FIXX Homology Medicines	5/17/2022	Target Lowered by	Chardan Capital	Analyst M. Barcus	NA	$14.00	High
BTTX Better Therapeutics	5/16/2022	Target Lowered by	Chardan Capital	Analyst K. Nakae	NA	$15.00	Low
MGTX MeiraGTx	5/13/2022	Reiterated by	Chardan Capital	Analyst Geulah Livshits	Buy	$46.00	Medium
SABS SAB Biotherapeutics	5/13/2022	Target Lowered by	Chardan Capital	Analyst K. Nakae		$10.00 -> $7.00	High
IMNM Immunome	5/13/2022	Target Lowered by	Chardan Capital			$16.00 -> $9.00	High
CRSP CRISPR Therapeutics	5/10/2022	Target Lowered by	Chardan Capital			$171.00 -> $168.00	High
OCGN Ocugen	5/9/2022	Target Lowered by	Chardan Capital	Analyst D. Gataulin	Neutral -> Neutral	$4.00 -> $3.50	High
AXLA Axcella Health	5/9/2022	Target Lowered by	Chardan Capital		Buy	$12.00 -> $7.00	High

EBS Emergent BioSolutions	4/29/2022	Target Lowered by	Chardan Capital			$75.00 -> $65.00	High
SLDB Solid Biosciences	4/28/2022	Target Lowered by	Chardan Capital			$255.00 -> $105.00	High
VBLT Vascular Biogenics	4/28/2022	Initiated by	Chardan Capital	Analyst M. Barcus	Buy	$5.00	High
PRQR ProQR Therapeutics	4/14/2022	Target Lowered by	Chardan Capital		Buy	$8.00 -> $2.50	High
RGNX REGENXBIO	4/11/2022	Reiterated by	Chardan Capital	Analyst D. Gataulin	Buy		Medium
KOD Kodiak Sciences	4/11/2022	Reiterated by	Chardan Capital	Analyst D. Gataulin	Buy		High
ADVM Adverum Biotechnologies	4/11/2022	Reiterated by	Chardan Capital	Analyst D. Gataulin	Neutral		Medium
OCGN Ocugen	4/11/2022	Reiterated by	Chardan Capital	Analyst D. Gataulin	Neutral		High
SABS SAB Biotherapeutics	4/1/2022	Target Lowered by	Chardan Capital	Analyst K. Nakae	Buy	$17.00 -> $10.00	Low
VINC Vincerx Pharma	3/29/2022	Reiterated by	Chardan Capital	Analyst Y. Livshits	Buy		Low
IMVT Immunovant	3/29/2022	Reiterated by	Chardan Capital	Analyst Y. Livshits	Buy		Medium
FIXX Homology Medicines	3/29/2022	Reiterated by	Chardan Capital	Analyst Y. Livshits	Buy		High
TSHA Taysha Gene Therapies	3/31/2022	Target Lowered by	Chardan Capital			$60.00 -> $37.00	High
WBX Wallbox	3/31/2022	Initiated by	Chardan Capital		Buy	$19.00	Low
OUST Ouster	3/31/2022	Initiated by	Chardan Capital		Buy	$70.00	High
SLN Silence Therapeutics	3/31/2022	Initiated by	Chardan Capital	Analyst K. Nakae	Buy	$33.00	Low
QURE uniQure	3/30/2022	Target Lowered by	Chardan Capital	Analyst M. Barcus		$95.00 -> $65.00	Low
VINC Vincerx Pharma	3/30/2022	Target Lowered by	Chardan Capital	Analyst M. Barcus		$30.00 -> $14.00	Low
IMVT Immunovant	3/30/2022	Target Lowered by	Chardan Capital	Analyst M. Barcus		$20.00 -> $14.00	High
IMNM Immunome	3/30/2022	Target Lowered by	Chardan Capital			$21.00 -> $16.00	High
RGNX REGENXBIO	3/29/2022	Target Lowered by	Chardan Capital			$90.00 -> $76.00	High
OCGN Ocugen	3/29/2022	Target Lowered by	Chardan Capital			$4.50 -> $4.00	High
KOD Kodiak Sciences	3/29/2022	Target Lowered by	Chardan Capital			$82.50 -> $19.00	High
VINC Vincerx Pharma	3/22/2022	Reiterated by	Chardan Capital	Analyst M. Barcus	Buy		Medium
QURE uniQure	3/22/2022	Reiterated by	Chardan Capital	Analyst M. Barcus	Buy		Medium
IMVT Immunovant	3/22/2022	Reiterated by	Chardan Capital	Analyst M. Barcus	Buy		Low
FIXX Homology Medicines	3/22/2022	Reiterated by	Chardan Capital	Analyst M. Barcus	Buy		Low
FEMY Femasys	3/25/2022	Target Lowered by	Chardan Capital		Buy	$25.00 -> $18.00	Medium
BTTX Better Therapeutics	3/16/2022	Target Raised by	Chardan Capital	Analyst K. Nakae	Buy	$17.00 -> $18.00	High
PASG Passage Bio	3/11/2022	Target Lowered by	Chardan Capital			$43.00 -> $34.00	Low
VYGR Voyager Therapeutics	3/9/2022	Target Raised by	Chardan Capital			$4.00 -> $6.00	High
ABUS Arbutus Biopharma	3/4/2022	Target Raised by	Chardan Capital		Buy	$5.50 -> $6.00	High
PLBY PLBY Group	3/2/2022	Target Lowered by	Chardan Capital		Buy	$49.00 -> $39.00	High
NTLA Intellia Therapeutics	3/1/2022	Target Lowered by	Chardan Capital	Analyst Geulah Livshits	Buy	$177.00 -> $172.00	High
EDIT Editas Medicine	2/25/2022	Target Lowered by	Chardan Capital	Analyst Geulah Livshits	Buy	$75.00 -> $60.00	High
IOVA Iovance Biotherapeutics	2/25/2022	Target Lowered by	Chardan Capital		Buy	$50.00 -> $45.00	High
FIXX Homology Medicines	2/22/2022	Target Lowered by	Chardan Capital		Buy	$25.00 -> $15.00	High
PRQR ProQR Therapeutics	2/14/2022	Target Lowered by	Chardan Capital	Analyst Keay Nakae	Buy	$18.00 -> $8.00	High
ALNY Alnylam Pharmaceuticals	2/11/2022	Reiterated by	Chardan Capital	Analyst Keay Nakae	Buy	$200.00	Medium
TNYA Tenaya Therapeutics	1/17/2022	Reiterated by	Chardan Capital	Analyst Y. Livshits	Buy		Low
LICY Li-Cycle	1/13/2022	Target Raised by	Chardan Capital		Buy	$17.00 -> $18.00	Medium
IMVT Immunovant	1/5/2022	Target Lowered by	Chardan Capital	Analyst M. Barcus	Buy -> Buy	$22.00 -> $20.00	High
NVVE Nuvve	12/21/2021	Initiated by	Chardan Capital		Buy	$24.00	High
VINC Vincerx Pharma	12/17/2021	Reiterated by	Chardan Capital	Analyst Geulah Livshits	Buy	$30.00	Medium
RCKT Rocket Pharmaceuticals	12/15/2021	Target Raised by	Chardan Capital	Analyst Geulah Livshits	Buy	$56.00 -> $60.00	High
ABUS Arbutus Biopharma	12/2/2021	Target Raised by	Chardan Capital		Buy	$5.00 -> $5.50	High
BTTX Better Therapeutics	11/24/2021	Initiated by	Chardan Capital	Analyst K. Nakae	Buy	$17.00	High
BMTX BM Technologies	11/23/2021	Initiated by	Chardan Capital		Buy	$21.00	High
LTRY Lottery.com	11/23/2021	Initiated by	Chardan Capital		Buy	$14.00	Medium
VLN Valens Semiconductor	11/23/2021	Initiated by	Chardan Capital		Buy	$13.00	High
LICY Li-Cycle	11/23/2021	Initiated by	Chardan Capital		Buy	$17.00	High
PLBY PLBY Group	11/23/2021	Initiated by	Chardan Capital		Buy	$49.00	Low
AXLA Axcella Health	11/16/2021	Target Raised by	Chardan Capital	Analyst Keay Nakae	Buy	$10.00 -> $12.00	Low
FIXX Homology Medicines	11/16/2021	Target Lowered by	Chardan Capital	Analyst M. Barcus	Buy	$30.00 -> $25.00	High
EBS Emergent BioSolutions	11/10/2021	Target Lowered by	Chardan Capital		Buy	$92.00 -> $75.00	Low
SABS SAB Biotherapeutics	11/5/2021	Initiated by	Chardan Capital	Analyst K. Nakae	Buy	$17.00	Low
ABUS Arbutus Biopharma	11/4/2021	Reiterated by	Chardan Capital		Buy		Medium
RGNX REGENXBIO	11/3/2021	Target Lowered by	Chardan Capital	Analyst Geulah Livshits	Buy	$100.00 -> $90.00	High
VYGR Voyager Therapeutics	11/2/2021	Target Lowered by	Chardan Capital	Analyst Y. Livshits	Neutral	$5.50 -> $4.00	Low
EVLO Evelo Biosciences	11/1/2021	Upgraded by	Chardan Capital	Analyst Keay Nakae	Neutral -> Buy	$12.00	Medium

MarketBeat Community Rating for Chardan Capital

Community Ranking:		2.7 out of 5 ( 2.7 of 5 stars)
Outperform Votes:		20,204 (Vote Outperform)
Underperform Votes:		16,831 (Vote Underperform)
Total Votes:		37,035

MarketBeat's community ratings are surveys of what our community members think about Chardan Capital and other research firms. Vote "Outperform" if you believe Chardan Capital's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Chardan Capital's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Chardan Capital Analyst Recommendations & Stock Picks

MarketBeat Community Rating for Chardan Capital

Stock Ratings Reports and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info